This is a service of EIN News a digital news provider
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
Advair News is an EIN News Service for health professionals. Constantly updated news and information about health.
FORMATS: RSS | EMAIL

Latest Advair News

  • New treatment uses heat to treat severe asthma 26 Nov 2009 01:14 GMT
    ... 1980. There is no cure for asthma. Treatments include avoiding allergy triggers and medications. Inhaled ... are experiencing symptoms. A recent Food and Drug Administration analysis of four drugs used to ... used to treat asthma -- including Serevent, Advair, Foradil and Symbicort -- found the drugs ...

  • Against expectations, genetic variation does not alter asthma treatment response 24 Nov 2009 13:33 GMT
    ... expectations, genetic variation does not alter asthma treatment response (PhysOrg.com) -- Studies have suggested that ... this treatment should be continued, School of Medicine researchers report. might not respond as well ... medications, inhaled steroids and long-acting beta-agonists (tradenames Advair or Symbicort), which are widely prescribed for ...

  • FDA panel backs expansion of Spiriva label 20 Nov 2009 12:56 GMT
    ... FDA panel backs expansion of Spiriva label Pfizer and ... disease blockbuster Spiriva. The US Food and Drug Administration’s Pulmonary-Allergy Drugs Advisory Committee has voted ... days and which require a change in treatment (antibiotics or steroids), which could include hospitalisation. ...

  • Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products - new report 20 Nov 2009 11:34 GMT
    ... commercial mileage from all components of a drug company’s portfolio is clearly evident in an era ... In light of the increasing complexity of biopharmaceutical patenting, the ‘freedom to operate’, i.e. to ... contextual reference points. Case studies on Vytorin, Advair and BiDil illustrate the strategies employed by ...

  • UPDATE 2-US panel backs new claim for Pfizer lung drug 19 Nov 2009 23:18 GMT
    ... a deadly lung disease. A Food and Drug Administration advisory panel, in an 11-1 vote, said ... a claim held by GlaxoSmithKline's rival drug Advair. Spiriva is considered the gold standard for ... Ohio State University's College of Pharmacy. The FDA usually follows panel recommendations. Winning approval for ...

  • UPDATE 1-US panel backs new claim for Pfizer lung drug 19 Nov 2009 21:13 GMT
    ... a blockbuster lung medicine. A Food and Drug Administration advisory panel, in an 11-1 vote, said ... flare-ups, a claim held by GlaxoSmithKline's rival Advair. The FDA committee also said current data were adequate ...

  • US FDA staff question Pfizer lung drug data 18 Nov 2009 02:30 GMT
    ... US FDA staff question Pfizer lung drug data * Boehringer, Pfizer seek new claim ... Spiriva is currently considered the gold standard treatment for COPD, or "smoker's lung," commonly caused ... claim made by GlaxoSmithKline's competing drug Advair. FDA reviewers, in an analysis prepared for ...

  • CORRECTED - UPDATE 3-US FDA staff question Pfizer lung drug data 18 Nov 2009 01:54 GMT
    ... statistical issues, safety concerns * Boehringer says drug not linked with more deaths (Corrects to ... Spiriva is currently considered the gold standard treatment for COPD, or "smoker's lung," commonly caused ... claim made by GlaxoSmithKline's competing drug Advair. FDA reviewers, in an analysis prepared for ...

  • CORRECTED-UPDATE 3-US FDA staff question Pfizer lung drug data 17 Nov 2009 23:34 GMT
    ... a proposed new claim for a lung drug sold by and Boehringer Ingelheim, documents released ... Spiriva is currently considered the gold standard treatment for COPD, or 'smoker's lung,' commonly caused ... a claim made by GlaxoSmithKline's competing drug Advair. FDA reviewers, in an analysis prepared for ...

  • US FDA staff question Pfizer's lung drug data 17 Nov 2009 23:15 GMT
    ... statistical issues, safety concerns * Boehringer says drug not linked with more deaths WASHINGTON, Nov ... Spiriva is currently considered the gold standard treatment for COPD, or "smoker's lung," commonly caused ... claim made by GlaxoSmithKline's competing drug Advair. FDA reviewers, in an analysis prepared for ...

  • UPDATE 3-US FDA staff question Pfizer lung drug data 17 Nov 2009 22:34 GMT
    ... a proposed new claim for a lung drug sold by and Boehringer Ingelheim, documents released ... Spiriva is currently considered the gold standard treatment for COPD, or 'smoker's lung,' commonly caused ... a claim made by GlaxoSmithKline's competing drug Advair. FDA reviewers, in an analysis prepared for ...

  • UPDATE 2-US FDA staff question Pfizer's lung drug data 17 Nov 2009 20:53 GMT
    ... a proposed new claim for a lung drug sold by and Boehringer Ingelheim, documents released ... Spiriva is currently considered the gold standard treatment for COPD, or 'smoker's lung,' commonly caused ... a claim made by GlaxoSmithKline's competing drug Advair. FDA reviewers, in an analysis prepared for ...


1 - 15 / 22      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS ADVAIR NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

Is Belgian Prime Minister Herman Van Rompuy the right person to lead the EU as its president? (Nov. 20, 2009)



 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.